# Drug Discovery

## CHEM-4330

This course will examine how bioinformatics, functional genomics, and other modern biotechnologies are used to speed the discovery of new drugs, especially those small organic molecules to treat human diseases with large unmet therapeutic need. Special emphasis will be placed on molecular target identification and validation as well as high-throughput screening to identify a lead. Topics to be discussed will include transgenic mice, RNA interference, DNA and protein microarrays, homogenous time-resolved fluorescence bioassays, phage-display, combinatorial chemistry, and parallel synthesis.

3 credits
Cross-listed with:
CHEM-6330 Drug Discovery
Prereqs:
one of:
CHEM-2220 Organic Synthesis CHEM-2260 Organic Chemistry II

# Past Term Data
Offered
Not Offered
Offered as Cross-Listing Only
No Term Data
Simple View
Detailed View

| Spring | Summer | Fall
--- | --- | --- | ---
| (Session 1) | (Session 2) |
2025 |  |  |
2024 |  |  |
2023 |  |  |
2022 |  |  |
2021 |  |  |
2020 |  |  |
2019 |  |  |
2018 |  |  |
2017 |  |  |
2016 |  |  |
2015 |  |  |
2014 |  |  |
2013 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 34/43
2012 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 26/43
2011 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 30/43
2010 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 24/43
2009 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 25/43
2008 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 24/48
2007 |  |  | Drug Discovery (3c) Mark Wentland Seats Taken: 31/48
2006 |  |  | Drug Discovery (3c) [WI] Mark Wentland Seats Taken: 34/40
2005 |  |  |
2004 | Drug Discovery (4c) [WI] Mark Wentland Seats Taken: 15/32 |  | Drug Discovery (3c) [WI] Mark Wentland Seats Taken: 11/20
2003 | Drug Discovery (4c) [WI] Mark Wentland Seats Taken: 18/32 |  |
2002 | Drug Discovery (4c) [WI] Mark Wentland Seats Taken: 14/16 |  |
2001 | Drug Discovery (4c) [WI] Mark Wentland Seats Taken: 14/32 |  |
2000 |  |  |
1999 |  |  |
1998 |  |  |